Literature DB >> 30802541

The tumour suppressor effects and regulation of cancer stem cells by macrophage migration inhibitory factor targeted miR-451 in colon cancer.

Afraa Mamoori1, Riajul Wahab2, Jelena Vider3, Vinod Gopalan4, Alfred King-Yin Lam5.   

Abstract

BACKGROUND: This study aimed to investigate the impact of miR-451 on the biological behaviours of colon cancer cells along with its targets interactions.
METHOD: The levels of miR-451 were tested in colon cancer cell lines (SW480 and SW48). Multiple functional and immunological assays were performed to analyse miR-451 induced growth changes in-vitro and downstream effects on target proteins.
RESULTS: Overexpression of miR-451 in colon cancer cells led to reduced cell proliferation, increased apoptosis and decrease accumulation of the cells at the G0/G1 phase of the cell cycle. In addition, a significant increase in the number of the cells was noted in the G2-M phase of cell cycle. Moreover, miR-451 reduced the expression of Oct-4, Sox-2 and Snail indicating its role in stem cell and epithelial-mesenchymal transition (EMT) regulation. An inverse correlation between miR-451 and macrophage migration inhibitory protein (MIF) protein expression occurred in colon cancer cells. Furthermore, restoration the level of miR-451 in colon cancer cells inhibits tumour spheres formation.
CONCLUSION: miR-451 has tumour suppressor effects in vitro, which can inhibit the cancer-related signalling pathways in colon cancer.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Colorectal carcinoma; Stem cell, EMT; miR-451

Mesh:

Substances:

Year:  2019        PMID: 30802541     DOI: 10.1016/j.gene.2019.02.046

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  13 in total

1.  Swimming prevents nonalcoholic fatty liver disease by reducing migration inhibitory factor through Akt suppression and autophagy activation.

Authors:  Haiying Tang; Xiaoyan Tan; Lei Zhu; Kairong Qin; Huan Gao; Hao Bai
Journal:  Am J Transl Res       Date:  2019-07-15       Impact factor: 4.060

Review 2.  Processing body (P-body) and its mediators in cancer.

Authors:  Bernard Nsengimana; Faiz Ali Khan; Ebenezeri Erasto Ngowi; Xuefeng Zhou; Yu Jin; Yuting Jia; Wenqiang Wei; Shaoping Ji
Journal:  Mol Cell Biochem       Date:  2022-01-28       Impact factor: 3.396

3.  Dysregulated expression of microRNAs acts as prognostic and diagnostic biomarkers for glioma patients.

Authors:  Yusrah Masood; Manahil Shal; Muhammad Furqan Shah; Maria Fazal Ul Haq; Mahmmood Akhtar Kayani; Ishrat Mahjabeen
Journal:  Mol Genet Genomics       Date:  2022-07-19       Impact factor: 2.980

Review 4.  Anaplastic Thyroid Carcinoma: Current Issues in Genomics and Therapeutics.

Authors:  Ichiro Abe; Alfred King-Yin Lam
Journal:  Curr Oncol Rep       Date:  2021-02-13       Impact factor: 5.075

5.  miR‑451 suppresses the malignant characteristics of colorectal cancer via targeting SAMD4B.

Authors:  Chunrong Wu; Xiaohu Liu; Bo Li; Guiying Sun; Chunfang Peng; Debing Xiang
Journal:  Mol Med Rep       Date:  2021-06-10       Impact factor: 2.952

Review 6.  Noncoding RNAs as Promising Diagnostic Biomarkers and Therapeutic Targets in Intestinal Fibrosis of Crohn's Disease: The Path From Bench to Bedside.

Authors:  Long-Yuan Zhou; Si-Nan Lin; Florian Rieder; Min-Hu Chen; Sheng-Hong Zhang; Ren Mao
Journal:  Inflamm Bowel Dis       Date:  2021-06-15       Impact factor: 7.290

7.  Clinicopathological significance of the EMT-related proteins and their interrelationships in prostate cancer. An immunohistochemical study.

Authors:  Martyna Parol-Kulczyk; Arkadiusz Gzil; Joanna Maciejewska; Magdalena Bodnar; Dariusz Grzanka
Journal:  PLoS One       Date:  2021-06-22       Impact factor: 3.240

8.  Plasma Level Of miR-21 And miR-451 In Primary And Recurrent Breast Cancer Patients.

Authors:  Maryam Motamedi; Morteza Hashemzadeh Chaleshtori; Sorayya Ghasemi; Fariborz Mokarian
Journal:  Breast Cancer (Dove Med Press)       Date:  2019-10-25

Review 9.  Emerging Role of the Macrophage Migration Inhibitory Factor Family of Cytokines in Neuroblastoma. Pathogenic Effectors and Novel Therapeutic Targets?

Authors:  Eugenio Cavalli; Rosella Ciurleo; Maria Cristina Petralia; Paolo Fagone; Rita Bella; Katia Mangano; Ferdinando Nicoletti; Placido Bramanti; Maria Sofia Basile
Journal:  Molecules       Date:  2020-03-06       Impact factor: 4.411

Review 10.  miR-451: A Novel Biomarker and Potential Therapeutic Target for Cancer.

Authors:  Hua Bai; Suhui Wu
Journal:  Onco Targets Ther       Date:  2019-12-16       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.